Using the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model to address risky substance use in New York City STD clinics: Are we in the right neighborhoods?

Wolff, Margaret

Annual Meeting Recordings are now available for purchase

307960
Using the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model to address risky substance use in New York City STD clinics: Are we in the right neighborhoods?

142nd APHA Annual Meeting and Exposition (November 15 - November 19, 2014): http://www.apha.org/events-and-meetings/annual

Tuesday, November 18, 2014

Margaret Wolff, MSW , Bureau of STD Control, New York City Department of Health and Mental Hygiene, Long Island City, NY

Raffaella Espinoza, MPH , Bureau of STD Control, New York City Department of Health and Mental Hygiene, Long Island City, NY

Meighan Rogers, MPH , Bureau of STD Control, New York City Department of Health and Mental Hygiene, Long Island City, NY

John Yu, Ph.D. , Research and Development, New York State Office of Alcoholism and Substance Abuse Services, Albany, NY

Brett Harris, MPH , Research and Development, New York State Office of Alcoholism and Substance Abuse Services, Albany, NY

Louis Cuoco, DSW, LCSW-R, ACSW , Bureau of Mental Health, New York City Department of Health and Mental Hygiene, Long Island City, NY

Susan Blank, MD, MPH , Bureau of STD Control, New York City Department of Health and Mental Hygiene, Long Island City, NY

Background: Alcohol/other drug (AOD) use has been associated with sexual risk-taking, sexually transmitted disease (STD)/HIV transmission, and excess mortality. To address this, Screening, Brief Intervention and Referral to Treatment (SBIRT) has been implemented in 6 New York City Department of Health and Mental Hygiene (NYCDOHMH) STD clinics since January 2010. Neighborhood-level AOD-related mortality rates were correlated with clinic locations to determine whether SBIRT is serving the highest-need populations.

Methods: From January 2010-December 2011, SBIRT screened 147,595 patients for risky AOD use. NYC Vital Statistics data were examined for 2010-2011 AOD-related mortality rates across the 42 NYC neighborhoods, grouped into high (top 21) and low (bottom 21) mortality neighborhoods, and correlated with SBIRT screening/interventions by NYC STD clinic location.

Results: From 2010-2011, alcohol-related mortality ranged 0.5 to 6.9 deaths/100,000; drug-related mortality 2.3 to 24.1 deaths/100,000. Neighborhoods shifted between high and low AOD-related mortality groups across years. Due to those shifts, in 2010, 4 SBIRT NYC STD clinics were located in high alcohol-related mortality neighborhoods, versus 1 in 2011; in 2010, 77% (n=3,407/4,404) of patients receiving brief interventions attended clinics in high alcohol-related mortality neighborhoods, versus 7% (n=246/3,479) in 2011. In 2010, 5 clinics were in high drug-related mortality neighborhoods versus 3 in 2011; in 2010, 83% (n=3,670/4,404) receiving brief interventions attended clinics in high drug-related mortality neighborhoods versus 65% (n=2,269/3,479) in 2011.

Conclusions: AOD-related mortality rates vary across neighborhoods over time. SBIRT has expanded to 7 NYCDOHMH STD clinics, which accommodates shifting AOD-related health risk trends and continues targeting high-need populations.

Learning Areas:

Conduct evaluation related to programs, research, and other areas of practice
Public health or related research
Social and behavioral sciences

Learning Objectives:
Describe the purpose of the SBIRT project in the context of urban STD clinics. Compare the provision of SBIRT services in relation to NYC neighborhood-level alcohol and drug-related mortality rates. Determine whether SBIRT services are reaching patients in high-need neighborhoods.

Keyword(s): Mortality

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I have worked as a project manager, data manager, and therapist on multiple federally funded longitudinal intervention studies focusing on the intersection between substance use and health outcomes. My personal research interests include investigating how substance use influences mental, physical, and behavioral health.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 4176.0: Screening for Substance Abuse in Medical Settings

142nd APHA Annual Meeting and Exposition

Online Program

307960 Using the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model to address risky substance use in New York City STD clinics: Are we in the right neighborhoods?

307960
Using the Screening, Brief Intervention, and Referral to Treatment (SBIRT) model to address risky substance use in New York City STD clinics: Are we in the right neighborhoods?